logo
Select company
Select metric
Ticker Information

Ticker

ASBP

Company Name

ASPIRE BIOPHARMA HOLDINGS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ASPIRE BIOPHARMA HOLDINGS INC - Return on Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ASBP - ROE Historical data
DateShareholders EquityNet Income Common StockReturn on Equity
6/30/2025$ -9.62M$ -18.9M0%
3/31/2025$ -6.95M$ -17.53M0%
12/31/2024$ -1.54M$ -1.31M0%
9/30/2024$ -6.51M$ -3.76M0%
6/30/2024$ -5.9M$ -3.29M0%
3/31/2024$ -2.57M$ -875.46K0%
12/31/2023$ -322.11K$ 4.46M0%
9/30/2023$ -62.95K$ 6.85M0%
6/30/2023$ 261.79K$ 7.99M3052.71%
3/31/2023$ -10.26M$ 6.3M0%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of Return on Equity

[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
Net Inc. Cmn. / Equity
(=) ROE
ROE for ASPIRE BIOPHARMA HOLDINGS INC is calculated as follows: Net Inc. Cmn. [ $ -25.48K ] / Equity [ $ -475 ]
(=) ROE [ 0% ]

ASBP - Return on Equity, Last 5 years

3052.71%

Minimum

Jun 30, 2023

3052.71%

Maximum

Jun 30, 2023

3052.71%

Average

3052.71%

Median

ROE Benchmark Analysis

The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
filtered constituents3.13K
min-66.24%
max73.25%
average1.63%
median6.53%
std22.52%